JP2023553835A5 - - Google Patents

Info

Publication number
JP2023553835A5
JP2023553835A5 JP2023532465A JP2023532465A JP2023553835A5 JP 2023553835 A5 JP2023553835 A5 JP 2023553835A5 JP 2023532465 A JP2023532465 A JP 2023532465A JP 2023532465 A JP2023532465 A JP 2023532465A JP 2023553835 A5 JP2023553835 A5 JP 2023553835A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
membered
independently
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023532465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023553835A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/063721 external-priority patent/WO2022133037A1/en
Publication of JP2023553835A publication Critical patent/JP2023553835A/ja
Publication of JP2023553835A5 publication Critical patent/JP2023553835A5/ja
Pending legal-status Critical Current

Links

JP2023532465A 2020-12-17 2021-12-16 大環状化合物およびそれらの使用 Pending JP2023553835A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063126722P 2020-12-17 2020-12-17
US63/126,722 2020-12-17
US202163279850P 2021-11-16 2021-11-16
US63/279,850 2021-11-16
US202163284789P 2021-12-01 2021-12-01
US63/284,789 2021-12-01
US202163289014P 2021-12-13 2021-12-13
US63/289,014 2021-12-13
PCT/US2021/063721 WO2022133037A1 (en) 2020-12-17 2021-12-16 Macrocycles and their use

Publications (2)

Publication Number Publication Date
JP2023553835A JP2023553835A (ja) 2023-12-26
JP2023553835A5 true JP2023553835A5 (cg-RX-API-DMAC7.html) 2024-12-24

Family

ID=82058646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023532465A Pending JP2023553835A (ja) 2020-12-17 2021-12-16 大環状化合物およびそれらの使用

Country Status (12)

Country Link
US (1) US20240182487A1 (cg-RX-API-DMAC7.html)
EP (1) EP4262796A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023553835A (cg-RX-API-DMAC7.html)
KR (1) KR20230121773A (cg-RX-API-DMAC7.html)
AU (1) AU2021401741A1 (cg-RX-API-DMAC7.html)
CA (1) CA3202770A1 (cg-RX-API-DMAC7.html)
IL (1) IL303419A (cg-RX-API-DMAC7.html)
MX (1) MX2023007162A (cg-RX-API-DMAC7.html)
PY (1) PY21110949A (cg-RX-API-DMAC7.html)
TW (1) TWI923651B (cg-RX-API-DMAC7.html)
UY (1) UY39574A (cg-RX-API-DMAC7.html)
WO (1) WO2022133037A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250022117A (ko) * 2022-06-08 2025-02-14 블로썸힐 테라퓨틱스, 인크. 인다졸 거대고리 화합물 및 그의 용도
AU2023282906A1 (en) * 2022-06-08 2024-11-28 Blossomhill Therapeutics, Inc. Indazole containing macrocycles and their use
CN119013283A (zh) * 2022-07-27 2024-11-22 上海和誉生物医药科技有限公司 大环egfr抑制剂及其制备方法和药学上的应用
JP2026507655A (ja) * 2023-02-22 2026-03-04 ユーハン・コーポレイション Egfr阻害剤としての大環状アミノピリジン化合物
JP2026507653A (ja) * 2023-02-22 2026-03-04 ユーハン・コーポレイション Egfr阻害剤としての大環状アミノピリジン化合物
CN120981466A (zh) * 2023-02-22 2025-11-18 柳韩洋行 作为egfr抑制剂的大环氨基吡啶化合物
WO2024209363A1 (en) 2023-04-06 2024-10-10 Pfizer Inc. Substituted indazole propionic acid derivative compounds and uses thereof as ampk activators
JP2026517554A (ja) * 2023-05-02 2026-06-02 ブロッサムヒル・セラピューティクス・インコーポレイテッド 疾患の処置のためのegfr阻害剤
JP2026521264A (ja) * 2023-06-23 2026-06-29 ブロッサムヒル・セラピューティクス・インコーポレイテッド 大環状インダゾール化合物の併用療法
TW202527935A (zh) * 2023-12-07 2025-07-16 美商榮山醫藥股份有限公司 吲唑巨環多晶型物
IL328856A (en) * 2023-12-08 2026-08-01 Blossomhill Therapeutics Inc Indazole-based macrocyclic compounds
WO2025199438A1 (en) * 2024-03-22 2025-09-25 Blossomhill Therapeutics, Inc. 7-azaindazole macrocycles and their use
WO2025245175A1 (en) * 2024-05-22 2025-11-27 Ajax Therapeutics, Inc. Macrocyclic heteroaromatic inhibitors of jak2
WO2026064346A1 (en) * 2024-09-18 2026-03-26 Blossomhill Therapeutics, Inc. Tetracyclic-macrocycles and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3062B1 (ar) * 2010-10-05 2017-03-15 Lilly Co Eli R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
CA2863892C (en) * 2012-03-06 2016-08-30 Pfizer Inc. Macrocyclic derivatives for the treatment of proliferative diseases
EP3333157B1 (en) * 2015-08-07 2020-12-23 Harbin Zhenbao Pharmaceutical Co., Ltd. Vinyl compounds as fgfr and vegfr inhibitors
CN111269245B (zh) * 2018-12-04 2021-08-27 杭州百新生物医药科技有限公司 一种环状氨基嘧啶衍生物及其抑制激酶的活性和用途
IL317393A (en) * 2018-12-21 2025-02-01 Revolution Medicines Inc Compounds that participate in covalent bonds and their uses

Similar Documents

Publication Publication Date Title
JP2022551185A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2013545818A5 (cg-RX-API-DMAC7.html)
JP2019529490A5 (cg-RX-API-DMAC7.html)
JP2018504437A5 (cg-RX-API-DMAC7.html)
JP2012530713A5 (cg-RX-API-DMAC7.html)
JP2022545633A5 (cg-RX-API-DMAC7.html)
JP2013545816A5 (cg-RX-API-DMAC7.html)
JP2023520924A5 (cg-RX-API-DMAC7.html)
JP2013545817A5 (cg-RX-API-DMAC7.html)
JP2023515618A5 (cg-RX-API-DMAC7.html)
WO2012107706A8 (en) Phenothiazine diaminium salts and their use
JP2012507522A5 (cg-RX-API-DMAC7.html)
JP2014510774A5 (cg-RX-API-DMAC7.html)
JP2015505296A5 (cg-RX-API-DMAC7.html)
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
JP2009516727A5 (cg-RX-API-DMAC7.html)
JP2014511876A5 (cg-RX-API-DMAC7.html)
JP2013507423A5 (cg-RX-API-DMAC7.html)
HU229935B1 (en) Dual action antibiotics
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2023537271A5 (cg-RX-API-DMAC7.html)
JP2009536221A5 (cg-RX-API-DMAC7.html)
JP2022537140A5 (cg-RX-API-DMAC7.html)
JP2023526050A5 (cg-RX-API-DMAC7.html)